High-sensitivity C-reactive protein is quite low in Japanese men at high coronary risk

Circulation Journal

Volumn 71, Issue 6, 2007, Pages 820-825

  Matsushita, Kunihiro ^a   Yatsuya, Hiroshi ^a   Tamakoshi, Koji ^a   Pei, Ou Yang ^a   Otsuka, Rei ^a   Wada, Keiko ^a   Mitsuhashi, Hirotsugu ^a   Hotta, Yo ^a   Kondo, Takahisa ^a   Murohara, Toyoaki ^a   Toyoshima, Hideaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Coronary heart disease; Framingham Risk Score; Japanese men

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; HIGH RISK POPULATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 34249654633     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.820     Document Type: Article

References (41)

1. Marmot M, Elliott P. Coronary heart disease epidemiology: From aetiology to public health. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: From aetiology to public health. New York: Oxford University Press; 2005; 3-7.
2. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
3. Levy D, Kannel WB. Searching for answers to ethnic disparities in cardiovascular risk. Lancet 2000; 356: 266-267.
4. Matsushita K, Yatsuya H, Tamakoshi K, Murohara T, Toyoshima H. Epidemiology of acute coronary syndrome. Nippon Rinsho 2006; 64: 625 - 632 (in Japanese).
5. Kodama K, Sasaki H, Shimizu Y. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: A 26-year follow-up, Hiroshima/Nagasaki Study. Jpn Circ J 1990; 54: 414-421.
6. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama Study. Stroke 2003; 34: 2349-2354.
7. Kitamura A, Iso H, Iida M, Naito Y, Sato S, Jacobs DR Jr, et al. Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994. Am J Med 2002; 112: 104-109.
8. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004; 109(Suppl 1): III-15-III-19.
9. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(Suppl 1): II-2-II-10.
10. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
11. Sakkinen P, Abbott RD, Curb JD, Rodriguez BL, Yano K, Tracy RP. C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55: 445-451.
12. Yano K, MacLean CJ, Reed DM, Shimizu Y, Sasaki H, Kodama K, et al. A comparison of the 12-year mortality and predictive factors of coronary heart disease among Japanese men in Japan and Hawaii. Am J Epidemiol 1998; 127: 476-487.
13. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. Am J Epidemiol 2001; 153: 1183-1190.
14. Tamakoshi K, Yatsuya H, Kondo T, Hori Y, Ishikawa M, Zhang H, et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003; 27: 443-449.
15. Matsushita K, Yatsuya H, Tamakoshi K, Wada K, Otsuka R, Zhang H, et al. Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men. Atherosclerosis 2006; 188: 184-189.
16. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003; 167: 73-79.
17. Ichihara Y, Ohno J, Suzuki M, Anno T, Sugino M, Nagata K. Higher C-reactive protein concentration and white blood cell count in subjects with more coronary risk factors and/or lower physical fitness among apparently healthy Japanese. Circ J 2002; 66: 677-684.
18. Oda E, Oohara K, Abe A, Veeraveedu PT, Watanabe K, Kato K, et al. The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan. Circ J 2006; 70: 384-388.
19. Nakanishi N, Shiraishi T, Wada M. C-reactive protein concentration is more strongly related to metabolic syndrome in women than in men: The Minoh Study. Circ J 2005; 69: 386-391.
20. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
21. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-2304.
22. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004; 27: 2676-2681.
23. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100: 1481-1492.
24. D'Agostino RB, Grundy S, Sullivan LM, Wilson P, for the CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-187.
25. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 2003; 108: 161-165.
26. Hashimoto K, Kasayama S, Yamamoto H, Kurebayashi S, Kawase I, Koga M. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 2004; 21: 581-585.
27. Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, et al; Osaka Acute Coronary Insufficiency Study (OACIS) Group. Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. Am J Cardiol 2003; 91: 931-935.
28. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: The Hisayama Study. Stroke 2006; 37: 27-32.
29. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
30. Stamler J, Neaton JD, Garside DB, Daviglus ML. Current status: Six established major risk factors and low risk. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: From aetiology to public health. New York: Oxford University Press; 2005; 32-70.
31. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89: 1333-1445.
32. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-2825.
33. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 2004; 24: 1509-1515.
34. Sekikawa A, Kuller LH, Ueshima H, Park JE, Suh I, Jee SH, et al. Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States. Int J Epidemiol 1999; 28: 1044-1049.
35. Sekikawa A, Ueshima H, Satoh T, Kuller LH. Rise in mortality from coronary heart disease among post-World War II birth cohorts in Japan? Epidemiology 2000; 11: 738.
36. Toyoshima H, Yatsuya H. Progress and prevention of diseases of circulatory system of Japanese adults: Cardiac diseases. Junkanki Senmon-I 2000; 8: 55-62 (in Japanese, translated by the authors).
37. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: Potential benefits and risks. J Am Geriatr Soc 2003; 51: 101-115.
38. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004; 89: 3313-3318.
39. Milano mutant: The Limone sul Garda study. Circulation 2001; 103: 1949-1954.
40. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. High-density lipoprotein function: Recent advances. J Am Coll Cardiol 2005; 46: 1792-1798.
41. The Ministry of Foreign Affairs of Japan. Japanese descendants living outside of Japan. Available at: http://www.mofa.go.jp/mofaj/area/latinamerica/ gaiyo/mede/pdfs/nikkei.pdf (accessed July 14, 2006).